WallStSmart
FENC

Fennec Pharmaceuticals Inc

NASDAQ: FENC · HEALTHCARE · BIOTECHNOLOGY

$6.26
-6.57% today

Updated 2026-04-29

Market cap
$235.81M
P/E ratio
P/S ratio
5.28x
EPS (TTM)
$-0.34
Dividend yield
52W range
$6 – $10
Volume
0.2M

Fennec Pharmaceuticals Inc (FENC) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-13.47M$-13.30M$-10.81M$-4.69M$-1.93M$-3.23M$-2.99M$-2.21M$-1.70M$-1.86M$-2.12M$-3.64M$-7.83M$-9.06M$-15.60M$-14.22M$-18.06M$-17.14M$26.98M$-12.47M
Capital expenditures$5000.00$73000.00$15000.00$0.00$0.00$1.44M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.00$0.00$0.00
Depreciation
Stock-based comp$2.49M$250000.00$326000.00$87000.00$627000.00$97000.00$615000.00$1.52M$1.82M$2.67M$2.79M$4.01M$4.22M$5.35M$5.06M$7.03M
Free cash flow$-13.48M$-13.38M$-10.82M$-4.69M$-1.93M$-4.67M$-2.99M$-2.21M$-1.70M$-1.86M$-2.12M$-3.64M$-7.83M$-9.06M$-15.60M$-14.22M$-18.06M$-17.14M$26.98M$-12.47M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$529164.00
Share repurchases
Debt repayment
Net change in cash$-640000.00$644000.00$-1.36M$2.98M$24.33M$-5.48M$-9.13M$16.69M$-9.24M